NEVRO
Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
NEVRO
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2006-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.nevro.com
Total Employee:
501+
Status:
Active
Contact:
6504333206
Total Funding:
355.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Font Awesome Amazon IPv6
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Board_member
Board_member
2019-10-01
Board_member
Board_member
Board_member
Board_member
2019-03-01
Board_member
Board_member
2020-12-01
Current Employees Featured
Niamh Pellegrini Chief Commercial Officer @ Nevro
Chief Commercial Officer
2019-07-01
Lori Ciano Chief Human Resources Officer @ Nevro
Chief Human Resources Officer
2019-06-01
Rod MacLeod Chief Financial Officer @ Nevro
Chief Financial Officer
2019-06-01
Keith Grossman Chairman & CEO @ Nevro
Chairman & CEO
2019-03-01
David Caraway Chief Medical Officer @ Nevro
Chief Medical Officer
2014-04-01
Christofer Christoforou Vice President, Research & Development @ Nevro
Vice President, Research & Development
2016-07-01
Kashif Rashid General Counsel @ Nevro
General Counsel
2017-01-01
Patrick Schmitz Vice President of Operations @ Nevro
Vice President of Operations
2016-01-01
Donald A. Middlebrook VP, Clinical, Regulatory, & Quality @ Nevro
VP, Clinical, Regulatory, & Quality
2020-01-01
Richard B. Carter Vice President of Finance @ Nevro
Vice President of Finance
2014-01-01
Founder
Stock Details
Investors List
CRG
CRG investment in Debt Financing - Nevro
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Series C - Nevro
MPM Capital
MPM Capital investment in Series C - Nevro
Novo Ventures
Novo Ventures investment in Series C - Nevro
Bay City Capital
Bay City Capital investment in Series C - Nevro
New Enterprise Associates
New Enterprise Associates investment in Series C - Nevro
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Nevro
Mayo Clinic
Mayo Clinic investment in Series C - Nevro
Covidien Ventures
Covidien Ventures investment in Series C - Nevro
Three Arch Partners
Three Arch Partners investment in Series C - Nevro
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-04 | Nevro appoints Stryker veteran as CFO |
Official Site Inspections
http://www.nevro.com Semrush global rank: 290.68 K Semrush visits lastest month: 223.05 K
Unable to get host informations!!!
More informations about "Nevro"
Nevro Corp. - Leadership Team
Christofer Christoforou joined Nevro in 2016 and was promoted to Chief Operating Officer in May 2024. In this role, Mr. Christoforou is responsible for leading Nevro’s manufacturing processes; …See details»
Nevro - Crunchbase Company Profile & Funding
Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating …See details»
Nevro Corp. - US - About - Overview
The Nevro ® Senza ® SCS System for 10 kHz Therapy received CE mark in 2010, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. Worldwide, tens of thousands of patients are enjoying …See details»
Nevro - LinkedIn
Nevro | 71,089 followers on LinkedIn. We Believe True Innovation Transforms More Lives | Nevro is a global medical device company focused on delivering innovation to improve the quality of …See details»
Nevro: Contact Details, Revenue, Funding, Employees and …
Nevro is a global medical device company dedicated to enhancing the lives of patients with chronic pain. Nevro’s solutions, HFX and SI Joint, combine advanced technology, optimized …See details»
Nevro Corp. (NVRO) Company Profile & Overview - Stock Analysis
Nov 6, 2014 Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company …See details»
Nevro - Funding, Financials, Valuation & Investors - Crunchbase
Nevro is registered under the ticker NYSE:NVRO . Their stock opened with $18.00 in its Nov 6, 2014 IPO. Nevro is funded by 13 investors. Braidwell and CRG are the most recent investors. …See details»
Nevro - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Nevro . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Nevro has 16 current employee profiles, including Chief Commercial …See details»
Nevro Corp. - Investors
2 days ago About Nevro. Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient …See details»
Nevro, our long-standing partner, has been acquired by Globus …
Feb 25, 2025 Information regarding Nevro’s directors and executive officers is set forth in Nevro’s proxy statement on Schedule 14A for its 2024 Annual Meeting of Stockholders, which …See details»
Mission, Vision & Core Values of Nevro – CANVAS, SWOT, PESTEL …
Oct 31, 2024 The Driving Force: Nevro's Mission: Inspiring innovation and dedication in the pursuit of pain relief. Envisioning the Future: Nevro's Vision: Transforming the way chronic …See details»
Nevro Announces Preliminary Fourth-Quarter and Full-Year
Jan 13, 2025 Nevro also provides minimally invasive treatment options for patients suffering from chronic sacroiliac joint ("SI joint") pain and offers the most comprehensive portfolio of …See details»
Nevro Corp. - Nevro Announces Consensus Statement Supporting …
Feb 1, 2024 Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the …See details»
Nevro Corp. - EN - Home
Discover the Latest Nevro News, Evidence, and Events. View All. All Superiority and Paresthesia-free claims are supported by the Senza Summary of Safety and Effectiveness Data (SSED). …See details»
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
18 hours ago REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing …See details»
What Are the Strategic Reasons Behind Globus Medical’s …
Nevro’s recent stock price decline presented a rare opportunity for Globus to acquire a company with significant growth potential at a much more favorable price. In the years leading up to the …See details»
Nevro Corp. (NVRO) Stock Price, News, Quote & History - Yahoo …
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides …See details»
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
1 day ago REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing …See details»
Nevro Corp. - US - About - Newsroom
YOU ARE ABOUT TO EXIT FOR A WEBSITE INTENDED FOR THE RESIDENTS OF ANOTHER COUNTRY OR REGION. Please be aware that the website you have requested is intended for …See details»
Nevro Corp. - Nevro Introduces HFX, New Comprehensive Brand …
REDWOOD CITY, Calif., April 26, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment …See details»